Brighton Jones’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,133
Closed -$4.75K – 1450
2026
Q2
$4.75K Buy
+11,133
New +$8.93K ﹤0.01% 1422

Other funds holding HRTX

Brighton Jones's HRTX Position: Q3 2026 in Review

Brighton Jones sold out of Heron Therapeutics (HRTX) in Q3 2026, closing a stake of 11,133 shares — an estimated $4.75K sold.

Brighton Jones first reported a position in HRTX in Q2 2026 and held it in 1 quarter. The position peaked at $4.75K in Q2 2026. 131 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.

  • Brighton Jones reported no remaining Heron Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 11,133 Heron Therapeutics shares in Q3 2026, an estimated $4.75K.
  • Brighton Jones first reported a position in Heron Therapeutics in Q2 2026 and held it in 1 quarter.
  • Brighton Jones's Heron Therapeutics position peaked at $4.75K in Q2 2026.
  • 131 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.